Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.'. Together they form a unique fingerprint.

    Medicine & Life Sciences